Abeona Therapeutics Inc. (ABEO) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Abeona Therapeutics Inc.
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa.…
Source: Yahoo Finance
Sector & Industry
Abeona Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Abeona Therapeutics Inc. at a Glance
| Company | Abeona Therapeutics Inc. |
| Ticker | ABEO |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $6.00 |
| Market cap | $343.10M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$1.21 |
| 52-week high | $7.65 |
| 52-week low | $4.00 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.32 |
| Return on equity (ROE) | -43.13% |
| Debt-to-equity | 15.52% |
| Average volume | 1.39M |
| Shares outstanding | 57.18M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 226 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Abeona Therapeutics Inc.'s current P/E ratio?
- Abeona Therapeutics Inc. (ABEO) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Abeona Therapeutics Inc.'s market capitalisation?
- Abeona Therapeutics Inc.'s market cap is $343.10M based on our latest snapshot. See how it ranks by market cap →
- What is ABEO's 52-week range?
- Over the past 52 weeks, ABEO has traded between $4.00 and $7.65. What does the 52-week range mean? →
- How volatile is Abeona Therapeutics Inc. compared to the market?
- Abeona Therapeutics Inc. has a beta of 1.32, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Abeona Therapeutics Inc. pay a dividend?
- Abeona Therapeutics Inc. does not currently pay a dividend according to our latest data.
- What exchange is ABEO listed on?
- ABEO is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Abeona Therapeutics Inc. in?
- Abeona Therapeutics Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →